Invicta Diagnostic Ltd vs Kk Shah Hospitals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Invicta Diagnostic Ltd is ₹ 89.5 as of 15 May 15:30 . The P/E Ratio of Invicta Diagnostic Ltd is 0 as of March 2024 .The P/E Ratio of KK Shah Hospitals Ltd is 0 as of March 2024 . The Market Cap of Invicta Diagnostic Ltd is ₹ 0 crore as of March 2024 .The Market Cap of KK Shah Hospitals Ltd is ₹ 0 crore as of March 2024 . The Dividend Payout of Invicta Diagnostic Ltd changed from 0 % on February 2023 to 0 % on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe Dividend Payout of KK Shah Hospitals Ltd changed from 55.82 % on March 2024 to 0 % on March 2025 . This represents a CAGR of -100.00% over 2 years .

About Invicta Diagnostic Ltd

Invicta Diagnostic Limited was incorporated as Limited Liability Partnership under the name 'Invicta Diagnostic LLP' vide Certificate of Incorporation dated January 22, 2021 issued by Assistant Registrar of Companies, Central Registration Centre.
Further, Invicta Diagnostic LLP converted into a Private Limited Company as 'Invicta Diagnostic Private Limited' dated December 01, 2023.
Subsequently, Company converted from a Private Limited to a Public Limited Company, and the name was changed to 'Invicta Diagnostic Limited' and a fresh Certificate of Incorporation dated July 02, 2024 was issued by the Central Processing Centre. Invicta Diagnostic Limited is an innovative diagnostic chain in Mumbai Metropolitan Region (MMR) offering comprehensive radiology and pathology solutions.
It offer a one-stop solution for pathology and radiology testing services such as imaging (including radiology) and pathology/clinical laboratory to customers through a network, consisting of 8 diagnostic centres and 1 centralised laboratory across Mumbai Metropolitan Region in Maharashtra.

About KK Shah Hospitals Ltd

KK Shah Hospitals Limited was incorporated under the name style of 'Jeevan Parv Healthcare Limited' on August 25, 2022 by the Central Registration Center, Manesar.
Subsequently, the Company changed its name from 'Jeevan Parv Healthcare Limited' to 'KK Shah Hospitals Limited' and a fresh certificate of incorporation on November 30, 2022 was issued by the Registrar of Companies, Gwalior, Madhya Pradesh.
The Company is engaged in the providing healthcare services. The Promoter, Dr. Kirti Kumar Shah started a clinic in Ratlam city in the year 1976 which further was transformed into a nursing home in the year 1991.
Subsequently, Dr. Kirti Kumar Shah established pediatrics care unit in 1991 under the name of 'Shah Maternity and Nursing Home'.
He started paediatric unit having Neonatal Intensive Care Unit (NICU) as an integral part of the Clinic in 1994.

FAQs for the comparison of Invicta Diagnostic Ltd and KK Shah Hospitals Ltd

Which company has a larger market capitalization, Invicta Diagnostic Ltd or KK Shah Hospitals Ltd?

Market cap of Invicta Diagnostic Ltd is 112 Cr while Market cap of KK Shah Hospitals Ltd is 28 Cr

What are the key factors driving the stock performance of Invicta Diagnostic Ltd and KK Shah Hospitals Ltd?

The stock performance of Invicta Diagnostic Ltd and KK Shah Hospitals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Invicta Diagnostic Ltd and KK Shah Hospitals Ltd?

As of May 18, 2026, the Invicta Diagnostic Ltd stock price is INR ₹89.5. On the other hand, KK Shah Hospitals Ltd stock price is INR ₹42.0.

How do dividend payouts of Invicta Diagnostic Ltd and KK Shah Hospitals Ltd compare?

To compare the dividend payouts of Invicta Diagnostic Ltd and KK Shah Hospitals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.